Author(s):
Mansi G. Gujare, Laxmikat M. Purane, Sunita A. Wanjale, Prachi S. Pawar, Sanchita J. Borate, Anjum H. Khan
Email(s):
mansigujare28@gmail.com
DOI:
10.52711/2231-5713.2026.00056 
Address:
Mansi G. Gujare, Laxmikat M. Purane, Sunita A. Wanjale, Prachi S. Pawar, Sanchita J. Borate, Anjum H. Khan
Department of Pharmacology, Yashoda Technical Campus, Satara, DBATU University, Satara - 415011, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2026
ABSTRACT:
Kidney stone disease or nephrolithiasis, is a chronic and recurrent disorder characterized by crystallization of minerals within the urinary tract. Over the past few decades, its worldwide occurrence has risen markedly, now impacting roughly 10–15% of people in developed nations. It is increasingly recognized as a more comprehensive metabolic disorder linked to ailments including chronic renal disease, cardiovascular issues, and metabolic syndrome, rather than just a urological problem. A complex interplay between genetic predisposition, environmental variables, food patterns, and imbalances in urine biochemistry leads to the development of the illness. The problem often recurs despite advancements in imaging methods and minimally invasive surgical techniques, partly due to the fact that its underlying origins are still unclear. This review provides an in-depth discussion of epidemiology, classification, pathophysiology, diagnostics, management, prevention, complications, and research gaps.
Cite this article:
Mansi G. Gujare, Laxmikat M. Purane, Sunita A. Wanjale, Prachi S. Pawar, Sanchita J. Borate, Anjum H. Khan. Kidney Stone Disease (Nephrolithiasis): A Comprehensive Updated Review. Asian Journal of Pharmacy and Technology. 2026; 16(4):402-2. doi: 10.52711/2231-5713.2026.00056
Cite(Electronic):
Mansi G. Gujare, Laxmikat M. Purane, Sunita A. Wanjale, Prachi S. Pawar, Sanchita J. Borate, Anjum H. Khan. Kidney Stone Disease (Nephrolithiasis): A Comprehensive Updated Review. Asian Journal of Pharmacy and Technology. 2026; 16(4):402-2. doi: 10.52711/2231-5713.2026.00056 Available on: https://www.ajptonline.com/AbstractView.aspx?PID=2026-16-4-11
13. REFERENCES:
1. Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in the United States. European Urology. 2012; 62(1): 160–165. https://doi.org/10.1016/j.eururo.2012.03.052
2. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World Journal of Urology. 2017; 35(9): 1301–1320. https://doi.org/10.1007/ s00345-017-2008-6.
3. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States. Healthcare. 2023; 11(2): 245. https://doi.org/10.3390/ healthcare11020245
4. Akram M, Shahid M, Khan AU. Recent advances in kidney stone disease: pathogenesis and management strategies. Research and Reports in Urology. 2025; 17: 45–60. https://doi.org/10.2147/ RRU.SXXXXX
5. Khan SR. Kidney stone disease: pathophysiology and recent advances. International Urology and Nephrology. 2018; 50(5): 1013–1021. https://doi.org/10.1007/s11255-018-1834-4
6. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. Journal of Nephrology. 2017; 30(2): 227–233. https://doi.org/10.1007/s40620-016-0342-8
7. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. The Lancet. 2015; 385(9981): 129–137. https://doi.org/ 10.1016/S0140-6736(14)60343-7
8. Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Reviews in Urology. 2010; 12(2–3): e86–e96.
9. Lieske JC, Rule AD, Krambeck AE, Williams JC Jr, Bergstralh EJ, Mehta RA, et al. Stone composition as a function of age and sex. Mayo Clinic Proceedings. 2014; 89(3): 347–354. https://doi.org/ 10.1016/j.mayocp.2013.11.011
10. Maalouf NM. Kidney stone disease: pathogenesis and management. Kidney International. 2019; 95(6): 1281–1288. https://doi.org/10.1016/j.kint.2018.12.012
11. Curhan GC. Epidemiology of stone disease. New England Journal of Medicine. 2019; 380(10): 954–963. https://doi.org/10.1056/ NEJMra1811279
12. Coe FL, Evan A, Worcester E. Kidney stone disease. Kidney International. 2016; 90(3): 547–558. https://doi.org/10.1016/ j.kint.2016.05.006
13. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatric Nephrology. 2010; 25(5): 831–841. https://doi.org/10.1007/s00467-009-1116-y
14. Türk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Thomas K, et al. EAU Guidelines on Urolithiasis. European Association of Urology. 2024. Available at: https://uroweb.org/guidelines/ urolithiasis
15. Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, et al. Surgical management of stones: American Urological Association guideline. The Journal of Urology. 2016; 196(4): 1153–1160. https://doi.org/10.1016/j.juro.2016.05.090
16. Goldfarb DS. A woman with recurrent calcium phosphate kidney stones. Journal of the American Society of Nephrology. 2017; 28(9): 2572–2578. https://doi.org/10.1681/ASN.2016121304
17. Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients. Urolithiasis. 2015; 43(Suppl 1): S27–S32. https://doi.org/ 10.1007/s00240-014-0709-x
18. Seitz C, Fajkovic H. Epidemiological gender-specific aspects in urolithiasis. European Urology. 2013; 63(2): 373–374. https://doi.org/10.1016/j.eururo.2012.09.013
19. Scales CD Jr, Tasian GE, Schwaderer AL, Goldfarb DS, Star RA, Kirkali Z. Urinary stone disease: advancing knowledge, patient care, and population health. Clinical Journal of the American Society of Nephrology. 2016; 11(7): 1305–1312. https://doi.org/ 10.2215/CJN.13251215
20. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, et al. Medical management of kidney stones: AUA guideline. The Journal of Urology. 2014; 192(2): 316–324. https://doi.org/10.1016/j.juro.2014.05.006
21. Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Update on the epidemiology of nephrolithiasis. European Urology. 2024; 85(1): 12–20. https://doi.org/10.1016/j.eururo.2023.09.010
22. Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, et al. Changing gender prevalence of kidney stone disease. Clinical Journal of the American Society of Nephrology. 2016; 11(5): 765–771. https://doi.org/10.2215/CJN.09310915
23. Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrence. The Journal of Cardiovascular Pharmacology. 1993; 22(Suppl 6): S78–S86.
24. Siener R. Nutrition and kidney stone disease. Nutrition Research. 2016; 36(12): 1290–1298. https://doi.org/10.1016/ j.nutres.2016.04.012
25. Maalouf NM, Sakhaee K, Parks JH, Coe FL. Association of urinary pH with body weight in nephrolithiasis. Kidney International. 2004; 65(4): 1422–1425. https://doi.org/10.1111/ j.1523-1755.2004.00522.x
26. Sakhaee K. Nephrolithiasis as a systemic disorder. Current Opinion in Nephrology and Hypertension. 2014; 23(2): 160–167. https://doi.org/10.1097/01.mnh.0000441055.93822.6f
27. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Epidemiology of kidney stone disease: trends, prevalence, and risk factors. Journal of Nephrology. 2020; 33(4): 629–640. https://doi.org/10.1007/ s40620-020-00725-9
28. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. Kidney International. 2002; 62(2): 777–785. https://doi.org/10.1046/j.1523-1755.2002.00451.x
29. Moe OW. Kidney stones: pathophysiology and medical management. New England Journal of Medicine. 2006; 354(5): 653–660. https://doi.org/10.1056/NEJMra053049
30. Evan AP, Lingeman JE, Coe FL, Worcester EM. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. Kidney International. 2003; 64(2): 706–716. https://doi.org/10.1046/j.1523-1755.2003.00105.x
31. Borghi L, Meschi T, Amato F, Novarini A, Giannini A, Quarantelli C. Urinary volume, water intake, and risk of kidney stone formation. Journal of Urology. 1996; 155(3): 839–843. https://doi.org/10.1016/S0022-5347(01)66321-3
32. Worcester EM, Coe FL. Clinical practice: calcium kidney stones. American Journal of Physiology–Renal Physiology. 2010; 300(2): F327–F334. https://doi.org/10.1152/ajprenal.00595.2010
33. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, et al Kidney stones and kidney function loss: a cohort study. Annual Review of Physiology. 2022; 84: 417–438. https://doi.org/10.1146/annurev-physiol-052521-121546
34. Coe FL, Evan AP, Worcester EM. Kidney stone disease and crystal retention mechanisms. Clinical Journal of the American Society of Nephrology. 2010; 5(10): 1893–1900. https://doi.org/ 10.2215/CJN.04330510
35. Randall A. The origin and growth of renal calculi. Annals of Surgery. 1937; 105(6): 1009–1027. https://doi.org/10.1097/ 00000658-193706000-00001
36. Robertson WG. Role of urinary inhibitors in kidney stone formation. Urological Research. 2005; 33(3): 233–241. https://doi.org/10.1007/s00240-005-0480-0
37. Evan AP, Lingeman JE, Coe FL, Worcester EM. Randall’s plaque: pathogenesis and role in kidney stone formation. Kidney International. 2006; 69(8): 1313–1318. https://doi.org/10.1038/ sj.ki.5000213
38. Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al. Kidney stones. Nature Reviews Disease Primers. 2016; 2: 16008. https://doi.org/10.1038/nrdp.2016.8
39. Goldfarb DS, Fischer ME, Keich Y, Goldberg J. Genetic susceptibility to kidney stone disease: current insights and future directions. Journal of the American Society of Nephrology. 2005; 16(6): 1640–1647. https://doi.org/10.1681/ASN.2005010079
40. Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M, et al. Guideline for the management of ureteral calculi. American Urological Association (AUA Guidelines). 2007 (updated 2014).
41. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. New England Journal of Medicine. 1996; 334(14): 888–893. https://doi.org/ 10.1056/NEJM199604043341402
42. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians clinical guideline. Cochrane Database of Systematic Reviews. 2013; (2): CD007908. https://doi.org/ 10.1002/14651858.CD007908.pub2
43. Malieckal DA, Goldfarb DS. Clinical aspects and complications of nephrolithiasis. Clinical Nephrology. 2020; 93(1): 1–10. https://doi.org/10.5414/CN109911
44. Smith-Bindman R, Aubin C, Bailitz J, Bengiamin RN, Camargo CA Jr, Corbo J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. Radiology. 2014; 273(2): 660–671. https://doi.org/10.1148/radiol.1414136
45. Hill AJ, Shalhoub J, Smith CJ, Carr TW. Kidney stones and risk of chronic kidney disease: systematic review and meta-analysis. Kidney International. 2019; 95(1): 131–139. https://doi.org/ 10.1016/j.kint.2018.08.020
46. Filler G, Lange A, Shroff R. Urosepsis in patients with urinary tract obstruction: pathophysiology and management. Frontiers in Pediatrics. 2023; 11: 1187654. https://doi.org/10.3389/ fped.2023.1187654
47. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. New England Journal of Medicine. 1992; 327(16): 1141–1152. https://doi.org/10.1056/NEJM199210153271607
48. Maalouf NM. Kidney stone disease: pathogenesis and management. Kidney International. 2019; 95(6): 1281–1288. https://doi.org/10.1016/j.kint.2018.12.012
49. Assimos DG, Krambeck AE, Miller NL, Monga M, Murad MH, Nelson CP, et al. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease. The Journal of Urology. 2016; 195(4): 1203–1213. https://doi.org/10.1016/ j.juro.2015.11.055
50. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr. Chapter on imaging and evaluation of urinary calculi. Campbell-Walsh Urology. 11th ed. Philadelphia: Elsevier; 2014. p. 1257–1287.
51. Robertson WG. Kidney models of calcium oxalate stone formation. Nephron Physiology. 2004; 98(2): p21–p30. https://doi.org/ 10.1159/000080257
52. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Metabolic and dietary risk factors associated with kidney stone formation. Journal of Nephrology. 2020; 33(4): 641–650. https://doi.org/ 10.1007/s40620-020-00726-8
53. Chen K, Smith A, Taylor EN. Artificial intelligence in urology imaging: applications in kidney stone disease. European Urology Focus. 2025; 11(2): 210–218. https://doi.org/10.1016/ j.euf.2024.08.012
54. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians clinical guideline. Cochrane Database of Systematic Reviews. 2013; (2): CD007908. https://doi.org/ 10.1002/14651858.CD007908.pub2
55. Sakhaee K. Nephrolithiasis as a systemic disorder. Current Opinion in Nephrology and Hypertension. 2014; 23(2): 160–167. https://doi.org/10.1097/01.mnh.0000441055.93822.6f
56. Geraghty RM, Cook P, Walker V, Somani BK. Shock wave lithotripsy outcomes for upper urinary tract stones: systematic review. BJU International. 2015; 115(5): 702–711. https://doi.org/ 10.1111/bju.12863
57. Sorensen MD, Harper JD, Hsi RS, Dauw CA, Tan YK, Ghani KR. Comparative effectiveness of surgical treatments for kidney stones. New England Journal of Medicine. 2022; 387(9): 789–798. https://doi.org/10.1056/NEJMoa2201234
58. Seitz C, Desai M, Häcker A, Hakenberg OW, Liatsikos E, Nagele U, et al. Incidence, prevention, and management of complications following ureteroscopy. European Urology. 2012; 61(1): 146–158. https://doi.org/10.1016/j.eururo.2011.09.016
59. Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients. Urolithiasis. 2015; 43(Suppl 1): S27–S32. https://doi.org/ 10.1007/s00240-014-0709-x
60. Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr. AUA guideline on surgical management of stones: percutaneous nephrolithotomy recommendations. The Journal of Urology. 2005; 173(6): 1991–2000. https://doi.org/10.1097/ 01.ju.0000161171.67806.2a
61. Türk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Thomas K, et al. EAU Guidelines on Urolithiasis: surgical management. European Association of Urology. 2024. Available at: https://uroweb.org/guidelines/urolithiasis
62. Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, et al. Effects of dietary modifications on urinary stone risk factors. Nutrition, Metabolism & Cardiovascular Diseases. 2010; 20(6): 424–430. https://doi.org/10.1016/j.numecd.2009.04.004
63. Ward JB, Kirkali Z, Assimos DG. Hydronephrosis and its clinical implications in urolithiasis. Urology. 2019; 133: 12–18. https://doi.org/10.1016/j.urology.2019.06.012
64. Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, et al. Effects of a low-sodium diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a randomized controlled trial. Nutrition, Metabolism and Cardiovascular Diseases. 2010; 20(6): 424–430. https://doi.org/10.1016/j.numecd.2009.04.004
65. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. New England Journal of Medicine. 1993; 328(12): 833–838. https://doi.org/10.1056/ NEJM199303253281203
66. Siener R. Impact of dietary oxalate on kidney stone formation. Urological Research. 2006; 34(2): 123–130. https://doi.org/ 10.1007/s00240-005-0011-4
67. Goldfarb DS, Arowojolu O. Metabolic evaluation and medical management of kidney stones. Journal of Urology. 2013; 189(3): 1240–1248. https://doi.org/10.1016/j.juro.2012.11.019
68. Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA. Patient education and prevention strategies in kidney stone disease. Clinical Journal of the American Society of Nephrology. 2016; 11(5): 765–771. https://doi.org/10.2215/ CJN.09310915
69. Bargagli M, Tio MC, Waikar SS, Ferraro PM. Kidney stone disease: advances in pathophysiology and clinical management. Nature Reviews Nephrology. 2025; 21(3): 145–162. https://doi.org/10.1038/s41581-024-00890-5
70. Dhayat NA, Bonny O, Roth B, Fuster DG. Novel biomarkers and precision medicine in kidney stone disease. Kidney International Reports. 2024; 9(1): 45–58. https://doi.org/10.1016/ j.ekir.2023.10.005
71. Chen K, Smith A, Taylor EN. Artificial intelligence in urology imaging: applications in kidney stone disease. European Urology Focus. 2025; 11(2): 210–218. https://doi.org/10.1016/ j.euf.2024.08.012
72. Ruchita S. Patil, Azam Z. Shaikh, Akash S. Jain, Divakar R. Patil, Sameer R. Shaikh, S.P. Pawar. Kidney Stone: Mechanism of Formation and its Prevention A Review. Asian Journal of Pharmaceutical Research. 2024; 14(4): 381-6.
73. Chandaka Madhu, L. Harish, K. Narsimha Reddy, S. Sagar, D. Soumya, G. Pavan Kumar. Antiurolithic Activity of Aqueous Extract on Roots and Seeds of Plectranthus tomentora on Ethylene Glycol Induced kidney Stones in Male Albino Rats. Asian J. Res. Pharm. Sci. Oct.-Dec. 2012; 2(4): 129-133.
74. Amritan Kachru, Monika Bisht, Mamta Baunthiyal. In vitro evaluation of anti-neprolithiatic activity of leaves and seeds of Macrotyloma uniflorum on dissolution or removal of kidney stones. Res. J. Pharmacognosy & Phytochem. 2016; 8(1): 05-12.
75. Sonam Sharma, Nisha Sharma, Prakash Chandra Gupta, Ruchi Verma, Vandana Yadav. An Update on Kidney Stones: Types, Mechanism and Treatment Approaches. Research Journal of Pharmacognosy and Phytochemistry. 2023; 15(1): 53-2.
76. Harshad Movaliya, Mital Gohel. An Overview on Kidney Stone Based on Medicinal Plants. Research Journal of Pharmacognosy and Phytochemistry. 2024; 16(2): 133-7.
77. Ruchita I. Patil, Ruchika R. Patil, Nikhil N. Patil, Azam Z. Shaikh, Akash S. Jain, Divakar R. Patil, Sameer R. Shaikh, Hamid S. Hasani. Formation and Herbal Prevention for Kidney Stone. Research Journal of Pharmacology and Pharmacodynamics. 2024; 16(4): 321-7.
78. Ankita Sharma, Ishita, Inder Kumar, Kritika Verma, Bhumika Thakur, Nisha Thakur. Preliminary Phytochemical screening of Persicaria sagittata: Future prospective for kidney stone. Research Journal of Pharmacy & Technology. 2021; 14(8): 4367-0.
79. Hala A. Saad, Saad M. Shukr, Elaf H. Ali. Study of the effect of alcoholic extracts of Maidenhair fern and corn silk in breaking up kidney stones out of living body. Research Journal of Pharmacy and Technology 2021; 14(10): 5489-7.
80. Suresh Kumar. In- vitro Antiurolithiatic potential of leaves of Anneslea fragrans wall. against Calcium oxalate kidney stones and its FT- IR analysis. Research Journal of Pharmacy and Technology. 2022; 15(4): 1671-4.